- Home
- NOVT
NOVT
Novanta Inc.
as of 12-16-2025 3:40pm EST
Novanta Inc manufactures photonic and motion-control components for original equipment manufacturers in the medical equipment and industrial technology markets. The firm operates in two segments: Automation Enabling Technologies and Medical Solutions. It generates the majority of its revenue from the Medical Solutions segment that designs, manufactures, and markets a range of medical-grade technologies, including medical insufflators, pumps, and related disposables; visualization solutions; and wireless technologies. The firm generates the majority of its revenue from the United States and Europe.
| Founded: | 1968 | Country: | United States |
| Employees: | N/A | City: | BEDFORD |
| Market Cap: | 3.8B | IPO Year: | N/A |
| Target Price: | $133.00 | AVG Volume (30 days): | 468.4K |
| Analyst Decision: | Hold | Number of Analysts: | 1 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | 1.46 | EPS Growth: | -12.05 |
| 52 Week Low/High: | $98.27 - $173.16 | Next Earning Date: | 11-03-2025 |
| Revenue: | $960,311,000 | Revenue Growth: | 4.07% |
| Revenue Growth (this year): | 5.1% | Revenue Growth (next year): | 6.75% |
AI-Powered NOVT Daily Prediction
Machine learning model trained on 25+ technical indicators
AI Recommendation
Disclaimer: This prediction is generated by an AI model and should not be considered as financial advice. Always conduct your own research and consult with financial professionals before making investment decisions.
Compare NOVT vs Leading Stocks
See how NOVT stacks up against similar companies in the market
Head-to-Head Comparisons
Share on Social Networks:
Tools & Resources
Enhance your trading experience with our free tools
Disclaimer
The information presented on this page, "NOVT Novanta Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.